drugset / Trial / NCT00198081
Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The purpose of the study is to find out whether the drug celecoxib has beneficial effects on people with pre-cancerous lesions of the pancreas.
Timeline
- Start
- 2005-09
- Primary completion
- 2012-04
- Completion
- 2012-04
Outcome
Outcome not reported
Stopped (Business): “Lack of funding and personnel to conduct study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Celecoxib | Other / unclassified | 400 mg | — |